Cardiac tamponade secondary prevention

Jump to navigation Jump to search

Cardiac tamponade Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Tamponade from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Cardiac tamponade secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Cardiac tamponade secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac tamponade secondary prevention

CDC on Cardiac tamponade secondary prevention

Cardiac tamponade secondary prevention in the news

Blogs on Cardiac tamponade secondary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Cardiac tamponade secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]; Hafiz M. Ahmed, M.D.[3]

Overview

Secondary prevention of cardiac tamponade focuses on preventing recurrent hemodynamic compromise after a pericardial effusion or tamponade episode. Strategies include treating the underlying cause, monitoring clinically significant effusions, using anti-inflammatory therapy when effusion is associated with active pericardial inflammation, and considering more durable drainage strategies in selected patients with recurrent large effusion or recurrent tamponade.

Secondary Prevention

  • The underlying cause of pericardial effusion should be identified and treated when possible.
  • Transthoracic echocardiography may be used for surveillance of pericardial effusions that are at least moderate in size.
  • Inflammatory pericardial effusion without concern for tamponade should generally be treated with anti-inflammatory therapy before pericardiocentesis is considered.
  • Pericardiocentesis is recommended for established or impending cardiac tamponade.
  • Surgical creation of a pericardial window may be considered in selected patients with recurrent large pericardial effusion and/or recurrent cardiac tamponade despite prior pericardiocentesis.[1]

References

  1. ↑ Wang TKM, Klein AL, Cremer PC, Imazio M, Kohnstamm S, Luis SA, Mardigyan V, Mukherjee M, Ordovas K, Vakamudi S, Wohlford GF. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2025;86(25):2691-2719. https://doi.org/10.1016/j.jacc.2025.05.023.

Template:WH Template:WS